Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 3
2(33.3%)
6Total
N/A(4)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07017634Phase 3Not Yet Recruiting

Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease

Role: lead

NCT06715345Not ApplicableActive Not Recruiting

Efficacy and Safety of Novosis Putty for Degenerative Lumbar Disease

Role: lead

NCT03469167Not ApplicableCompleted

Study to Evaluate Efficacy and Safety of Wound Dressing Solution Containing EGF in Patients With Peptic Ulcers Bleeding

Role: lead

NCT03089450Not ApplicableUnknown

To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent

Role: lead

NCT02957500Not ApplicableUnknown

To Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®)

Role: lead

NCT02940210Phase 3Unknown

Clinical Trial to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy

Role: lead

All 6 trials loaded